off brand semaglutide FDA warns about safety of 'off-brand' versions of Ozempic, Wegovy Seattle weight loss patients fret

It is safer and more cost-effective to replace it than to continue therapy with potentially inactive medication

Le Lan, C

For GLP-1 agonist non-responders, this delay often results in treatment abandonment

The change from baseline in the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS) and change in body weight were the primary end points

This could shave a few months off the timeline, particularly in the NDA preparation and launch phases

Cut back on fried foods, sugary drinks, refined carbs, and heavy alcohol, and focus on lean protein, vegetables, whole grains in sensible portions, and healthy fats